EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies

Emily McLeish, Nataliya Slater, Frank L Mastaglia, Merrilee Needham, Jerome D Coudert iD

Briefings in Bioinformatics · 22.11.2023 · 25 (1)

DOI: 10.1093/bib/bbad514 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, online erschienen am 17.01.2024. Verfasst von Emily McLeish und 4 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch University, Centre for Molecular Medicine and Innovative Therapeutics, Murdoch, Western Australia (WA), Australia. Hauptthemen laut MEDLINE: Myositis, Dermatomyositis, Autoimmune Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Brain Foundation and the Spinnaker Health Research Foundation, Perron Institute for Neurological and Translational Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic inflammatory myopathies (IIMs) are a heterogeneous group of muscle disorders including adult and juvenile dermatomyositis, polymyositis, immune-mediated necrotising myopathy and sporadic inclusion body myositis, all of which present with variable symptoms and disease progression. The identification of effective biomarkers for IIMs has been challenging due to the heterogeneity between IIMs and within IIM subgroups, but recent advances in machine learning (ML) techniques have shown promises in identifying novel biomarkers. This paper reviews recent studies on potential biomarkers for IIM and evaluates their clinical utility. We also explore how data analytic tools and ML algorithms have been used to identify biomarkers, highlighting their potential to advance our understanding and diagnosis of IIM and improve patient outcomes. Overall, ML techniques have great potential to revolutionize biomarker discovery in IIMs and lead to more effective diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyositisDermatomyositisAutoimmune DiseasesAdultHumansBiomarkersDisease Progression

Stichwörter der Autor:innen

biomarkersidiopathic inflammatory myopathiesmachine learningmyositis-specific autoantibodies

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Murdoch University, Centre for Molecular Medicine and Innovative Therapeutics, Murdoch, Western Australia (WA), Australia.
  • Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
  • University of Notre Dame Australia, School of Medicine, Fremantle, WA, Australia.
  • Fiona Stanley Hospital, Department of Neurology, Murdoch, WA, Australia.

ORCID-Profile: Jerome D Coudert

Förderung

  • Brain Foundation and the Spinnaker Health Research Foundation
  • Perron Institute for Neurological and Translational Science

Zitieren

APA

McLeish, E., Slater, N., Mastaglia, F. L., Needham, M., & Coudert, J. D. (2023). From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies. Briefings in Bioinformatics, 25(1). https://doi.org/10.1093/bib/bbad514

Vancouver

McLeish E, Slater N, Mastaglia FL, Needham M, Coudert JD. From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies. Briefings in Bioinformatics. 2023;25(1). doi:10.1093/bib/bbad514

BibTeX
@article{McLeish2023,
  author = {McLeish, Emily and Slater, Nataliya and Mastaglia, Frank L and Needham, Merrilee and Coudert, Jerome D},
  title = {From data to diagnosis: how machine learning is revolutionizing biomarker discovery in idiopathic inflammatory myopathies},
  journal = {Briefings in Bioinformatics},
  year = {2023},
  volume = {25},
  number = {1},
  doi = {10.1093/bib/bbad514}
}
Kostenlos starten →